CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research

Author(s):  
Fahreddin Palaz ◽  
Ali Kerem Kalkan ◽  
Özgür Can ◽  
Ayça Nur Demir ◽  
Abdullah Tozluyurt ◽  
...  
MicroRNA ◽  
2021 ◽  
Vol 10 ◽  
Author(s):  
Saiedeh Razi Soofiyani ◽  
Kamram Hosseini ◽  
Alireza Soleimanian ◽  
Liela Abkhooei ◽  
Akbar Mohammad Hoseini ◽  
...  

: MicroRNAs (miRNAs) are highly conserved non-coding RNAs involved in many physiological processes such as cell proliferation, inhibition, development of apoptosis, differentiation, suppresses tumorigenicity, and regulating cell growth. The description of the alterations of miRNA expression patterns in cancers will be helpful to recognize biomarkers for early detection and possible therapeutic intervention in the treatment of cancers. Recent studies have shown that miR-451 is broadly dysregulated in lung cancer and is a crucial agent in lung tumor progression. This review summarizes recent advances of the potential role of miR-451 in lung cancer diagnosis, prognosis, and treatment and provides an insight into the potential use of miR-451 for the development of advanced therapeutic methods in lung cancer.


2019 ◽  
Vol 7 (4) ◽  
pp. 1262-1275 ◽  
Author(s):  
Yifan Zhang ◽  
Kai Huang ◽  
Jing Lin ◽  
Peng Huang

Anisotropic Janus nanoparticles (JNPs), due to their several distinct merits, have been widely investigated for cancer theranostics.


2015 ◽  
Vol 47 (4) ◽  
pp. 1203-1210 ◽  
Author(s):  
RAMADEVI SUBRAMANI ◽  
LAXMAN GANGWANI ◽  
SUSHMITA BOSE NANDY ◽  
ARUNKUMAR ARUMUGAM ◽  
MUNMUN CHATTOPADHYAY ◽  
...  

2016 ◽  
Vol 18 (31) ◽  
pp. 21331-21339 ◽  
Author(s):  
Nanasaheb D. Thorat ◽  
O. M. Lemine ◽  
Raghvendra A. Bohara ◽  
Karim Omri ◽  
L. El Mir ◽  
...  

Nanoparticle-based cancer diagnosis-therapy integrative systems (cancer theranostics) represent an emerging approach in oncology.


Sign in / Sign up

Export Citation Format

Share Document